Browse All

Current Filters

CLEAR FILTER x

TITLE

Benefit-Risk Assessment Based on Number Needed to Treat and Number Needed to Harm: Atogepant vs Calcitonin Gene–Related Peptide Monoclonal Antibodies

Author:Sacco, Simona   Lalla, Anjana   Halker Singh, Rashmi   Holle-Lee, Dagney   Pozo-Rosich, Patricia   Nagy, Krisztian   Kelton, Kari   Piron, Cristiano   Gandhi, Pranav   Ailani, Jessica   

Session Name:P5: Headache: Advances in CGRP Inhibition 1  

Topic:Headache  

Program Number:P5.007  

Author Institution:University of L'Aquila, L'Aquila, Italy  AbbVie, Irvine, CA  Mayo Clinic, Scottsdale, AZ  Department of Neurology, West German Headache  Vertigo Center Essen, University of Essen, Essen, Germany  Vall d’Hebron University Hospital  Vall d’Hebron Institute of Research, Universitat Autònoma de Barcelona, Barcelona, Spain  AbbVie, Budapest, Hungary  Medical Decision Modeling Inc., Indianapolis, IN  AbbVie, Madison, NJ  Medstar Georgetown Neurology, McLean, VA